| 685828 |
FRONTIERS IN GENETICS |
A Timely Review of Cross-Kingdom Regulation of Plant-Derived MicroRNAs |
2021-05-03 |
10.3389/fgene.2021.613197 |
Li Dan, Yang Jianhui, Yang Yong, Liu Jianxin, Li Hui, Li Rongfei, Cao Chunya, Shi Liping, Wu Weihua, He Kai |
| 685827 |
FRONTIERS IN GENETICS |
Predicting Drug-Disease Association Based on Ensemble Strategy |
2021-05-03 |
10.3389/fgene.2021.666575 |
Wang Jianlin, Wang Wenxiu, Yan Chaokun, Luo Junwei, Zhang Ge |
| 685826 |
FRONTIERS IN ONCOLOGY |
The Impact of Intraoperative Frozen Section on Resection Margin Status and Survival of Patients Underwent Pancreatoduodenectomy for Distal Cholangiocarcinoma |
2021-05-03 |
10.3389/fonc.2021.650585 |
Chen Zhiqiang, Yu Bingran, Bai Jiaping, Li Qiong, Xu Bowen, Dong Zhaoru, Zhi Xuting, Li Tao |
| 685825 |
FRONTIERS IN ONCOLOGY |
Analysis of Gastric Cancer Transcriptome Allows the Identification of Histotype Specific Molecular Signatures With Prognostic Potential |
2021-05-03 |
10.3389/fonc.2021.663771 |
Carino Adriana, Graziosi Luigina, Marchianò Silvia, Biagioli Michele, Marino Elisabetta, Sepe Valentina, Zampella Angela, Distrutti Eleonora, Donini Annibale, Fiorucci Stefano |
| 685824 |
FRONTIERS IN ONCOLOGY |
SMAD4 Expression in Renal Cell Carcinomas Correlates With a Stem-Cell Phenotype and Poor Clinical Outcomes |
2021-05-03 |
10.3389/fonc.2021.581172 |
Rasti Arezoo, Madjd Zahra, Saeednejad Zanjani Leili, Babashah Sadegh, Abolhasani Maryam, Asgari Mojgan, Mehrazma Mitra |
| 685823 |
FRONTIERS IN ONCOLOGY |
Canine Parvovirus and Its Non-Structural Gene 1 as Oncolytic Agents: Mechanism of Action and Induction of Anti-Tumor Immune Response |
2021-05-03 |
10.3389/fonc.2021.648873 |
Arora Richa, Malla Waseem Akram, Tyagi Arpit, Mahajan Sonalika, Sajjanar Basavaraj, Tiwari Ashok Kumar |
| 685822 |
FRONTIERS IN ONCOLOGY |
Escape From Treatment; the Different Faces of Leukemic Stem Cells and Therapy Resistance in Acute Myeloid Leukemia |
2021-05-03 |
10.3389/fonc.2021.659253 |
van Gils Noortje, Denkers Fedor, Smit Linda |
| 685821 |
FRONTIERS IN ONCOLOGY |
Efficacy and Safety of Pyrotinib Versus T-DM1 in HER2+ Metastatic Breast Cancer Patients Pre-Treated With Trastuzumab and a Taxane: A Bayesian Network Meta-Analysis |
2021-05-03 |
10.3389/fonc.2021.608781 |
Liao Hao, Huang Wenfa, Liu Yaxin, Pei Wendi, Li Huiping |
| 685820 |
FRONTIERS IN ONCOLOGY |
Efficacy and Safety of Apatinib Treatment for Advanced Cholangiocarcinoma After Failed Gemcitabine-Based Chemotherapy: An Open-Label Phase II Prospective Study |
2021-05-03 |
10.3389/fonc.2021.659217 |
Zhang Ge, Gong Shuai, Pang Lina, Hou Lixia, He Wei |
| 685819 |
FRONTIERS IN ONCOLOGY |
Hypoxia-Induced MALAT1 Promotes the Proliferation and Migration of Breast Cancer Cells by Sponging MiR-3064-5p |
2021-05-03 |
10.3389/fonc.2021.658151 |
Shih Chung-Hsien, Chuang Li-Ling, Tsai Mong-Hsun, Chen Li-Han, Chuang Eric Y., Lu Tzu-Pin, Lai Liang-Chuan |
